WASHINGTON (MedPage Today) -- The FDA began a three-phase study of patient quality of life for those who have received laser-assisted in situ keratomileusis (LASIK).
FDA Monitors LASIK Safety and QualityCourtesy MedPage Today Surgery Fri, 10/16/2009 - 10:10
WASHINGTON (MedPage Today) -- The FDA began a three-phase study of patient quality of life for those who have received laser-assisted in situ keratomileusis (LASIK). More related itemsFDA OKs New Use for Aortic Graft
FDA Holds OJ Imports Pending Fungicide Testing
FDA Okays Hand-Held Scanner to Spot Clots in Brain
The Unwritten Rules of Friendship: Simple Strategies...
|
Popular by tags WeekMonth |
Post new comment